MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.
Two futures can help us picture the change. First, AGI as the ultimate market maker. Here, superfast agents set prices across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback